Alan Hennessy has been the Discovery and Exploratory Research Team Lead at GARDP since June 2023. Prior to this, Alan was head of lead generation and group leader at Syngenta, UK. During this time, several of the research projects he led successfully transitioned into development. Metproxybicyclone is the most advanced compound from these projects and is now in late development.
Alan also worked in anti-bacterial research for almost 10 years at GSK, leading diverse medicinal chemistry teams. He is an inventor on over 50 published patents including the key patent for GSK’s Phase 3 clinical candidate gepotidacin. He received his BSc and PhD from University College Dublin, Ireland and completed his postdoctoral research at Imperial College London, UK.